Fluorogenic substrate assay of antithrombin III: a clinical study. 1983

D A Triplett, and E I Banez, and C S Harms

The fluorogenic substrate assay of antithrombin III (AT III) was compared with a thrombin inhibition (two-stage) clotting test and a radial immunodiffusion assay. Normal ranges based on a population of 25 individuals were 88-121% (fluorogenic substrate), 72-111% (clotting) and 22.5-35.3 mg/dl (RID). A clinical comparison of the methods showed a linear relationship between the fluorogenic substrate and immunologic methods (r = 0.69, p less than 0.005), as well as between the fluorogenic substrate and clotting methods (r = 0.75, p less than 0.005). The fluorogenic substrate assay reflected the highest incidence of low AT III levels in all three clinical groups included (36 patients with arteriosclerosis, 18 with fractures and 37 with thrombosis/embolism).

UI MeSH Term Description Entries
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D012784 Shoulder Fractures Fractures of the proximal humerus, including the head, anatomic and surgical necks, and tuberosities. Humeral Fractures, Proximal,Humeral Head Fracture,Humeral Head Fracture Dislocation,Greater Tuberosity Fractures,Fracture, Greater Tuberosity,Fracture, Humeral Head,Fracture, Proximal Humeral,Fracture, Shoulder,Fractures, Shoulder,Greater Tuberosity Fracture,Head Fracture, Humeral,Humeral Fracture, Proximal,Humeral Head Fractures,Proximal Humeral Fracture,Proximal Humeral Fractures,Shoulder Fracture
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms

Related Publications

D A Triplett, and E I Banez, and C S Harms
February 1978, Thrombosis research,
D A Triplett, and E I Banez, and C S Harms
January 1975, Haemostasis,
D A Triplett, and E I Banez, and C S Harms
April 1979, Bollettino della Societa italiana di biologia sperimentale,
D A Triplett, and E I Banez, and C S Harms
September 1975, Thrombosis et diathesis haemorrhagica,
D A Triplett, and E I Banez, and C S Harms
January 1981, Annals of the New York Academy of Sciences,
D A Triplett, and E I Banez, and C S Harms
January 1982, Rinsho byori. The Japanese journal of clinical pathology,
D A Triplett, and E I Banez, and C S Harms
June 1974, Thrombosis et diathesis haemorrhagica,
D A Triplett, and E I Banez, and C S Harms
November 1990, Analytical biochemistry,
D A Triplett, and E I Banez, and C S Harms
August 1980, American journal of clinical pathology,
D A Triplett, and E I Banez, and C S Harms
December 1984, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!